ONESOURCE1,548.10

Onesource Specialty Pharma Ltd.

· Pharma & Health
₹ CrorePeersSTARDIVISLABGLANDPFIZERPOLYMEDRAINBOWKIMSJUBLPHARMAMcap ₹17,744 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt771.61,276.31,276.3
Net Debt606.21,235.21,235.2
Total Debt/Equity0.130.220.22
Net Debt/Equity0.100.210.21
Total Debt/EBITDA1.654.204.20
Net Debt/EBITDA1.304.063.64
Interest Coverage (EBIT/Interest)1.160.210.21
Total Debt/Total Capital %11.6017.9617.96
As Filed — company-reported covenants
Debt/Equity (as filed)0.16
Debt Service Coverage (as filed)0.63
Interest Service Coverage (as filed)1.52
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.